Mae platfform deallusrwydd artiffisial IBEX bellach yn cael ei brofi ymhellach mewn chwe bwrdd iechyd, gyda'r nod o ddefnyddio'r dechnoleg hon fel rhan o brofion rheolaidd am ganser y prostad, gan helpu timau clinigol i wneud diagnosis o ganserau eraill ac i asesu sut y gellir defnyddio'r dechnoleg er mwyn gwneud hynny.
The IBEX AI platform is now undergoing further testing within six health boards with the ambition to make this technology part of routine prostate cancer testing supporting clinical teams to and assess its use in the diagnosis of additional cancers.